SciHub
文献互助
期刊查询
一搜即达
科研导航
即时热点
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
thanks
Lv4
780 积分
2021-08-16 加入
最近求助
最近应助
互助留言
Cetuximab and vemurafenib plus FOLFIRI (5-fluorouracil/leucovorin/irinotecan) for BRAF V600E-mutated advanced colorectal cancer (IMPROVEMENT): An open-label, single-arm, phase II trial
1个月前
已完结
Pan Canadian Rash Trial: A Randomized Phase III Trial Evaluating the Impact of a Prophylactic Skin Treatment Regimen on Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor-Induced Skin Toxicities in Patients With Metastatic Lung Cancer
2个月前
已关闭
Erlotinib versus chemotherapy as first-line treatment for patients with advanced EGFR mutation-positive non-small-cell lung cancer (OPTIMAL, CTONG-0802): a multicentre, open-label, randomised, phase 3 study
2个月前
已完结
抗肿瘤药物相关皮肤不良反应管理专家共识
2个月前
已完结
Effect of BRAFV600E and TERT Promoter Mutations on Thyroglobulin Response in Patients With Distant-Metastatic Differentiated Thyroid Cancer
1年前
已完结
Prevalence of Postoperatively Detected High-risk Features in 2- to 4-cm Papillary Thyroid Cancers
1年前
已完结
The genetic duet of BRAF V600E and TERT promoter mutations predicts the poor curative effect of radioiodine therapy in papillary thyroid cancer
1年前
已完结
Advances in tests for colorectal cancer screening and diagnosis
1年前
已完结
Risk scoring based on DNA methylation-driven related DEGs for colorectal cancer prognosis with systematic insights
1年前
已完结
Circulating Tumor DNA Harboring the BRAFV600E Mutation May Predict Poor Outcomes of Primary Papillary Thyroid Cancer Patients
1年前
已完结
没有进行任何应助
thanks
1个月前
不找了【积分已退回】
2个月前
thanks
2个月前
thanks
2个月前
谢谢!
1年前
谢谢您!
1年前
谢谢!
1年前
谢谢!
1年前
谢谢!
1年前
谢谢!
1年前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论